vs
CRISPR Therapeutics AG（CRSP）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
RCI HOSPITALITY HOLDINGS, INC.的季度营收约是CRISPR Therapeutics AG的2.0倍（$70.9M vs $35.7M），RCI HOSPITALITY HOLDINGS, INC.净利率更高（-7.8% vs -104.5%，领先96.8%），RCI HOSPITALITY HOLDINGS, INC.同比增速更快（-3.1% vs -82.3%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $-50.3M）
CRISPR Therapeutics AG是一家瑞美合资生物技术企业，总部位于瑞士楚格，在美国以CRISPR Therapeutics, Inc.名义开展业务。作为首批依托CRISPR基因编辑平台开发药物的企业之一，公司现有约500名员工，在瑞士楚格、美国波士顿、旧金山及英国伦敦设有办公点，专注于多种罕见病与常见病的治疗药物研发。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
CRSP vs RICK — 直观对比
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.7M | $70.9M |
| 净利润 | $-37.3M | $-5.5M |
| 毛利率 | — | — |
| 营业利润率 | -181.0% | -0.7% |
| 净利率 | -104.5% | -7.8% |
| 营收同比 | -82.3% | -3.1% |
| 净利润同比 | -141.8% | -2354.9% |
| 每股收益（稀释后） | $-0.41 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q3 25 | — | $70.9M | ||
| Q2 25 | — | $71.1M | ||
| Q1 25 | — | $65.9M | ||
| Q4 24 | $35.7M | $71.5M | ||
| Q3 24 | — | $73.2M | ||
| Q2 24 | — | $76.2M | ||
| Q1 24 | — | $72.3M | ||
| Q4 23 | $201.2M | $73.9M |
| Q3 25 | — | $-5.5M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | $-37.3M | $9.0M | ||
| Q3 24 | — | $244.0K | ||
| Q2 24 | — | $-5.2M | ||
| Q1 24 | — | $774.0K | ||
| Q4 23 | $89.3M | $7.2M |
| Q3 25 | — | -0.7% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | -181.0% | 19.5% | ||
| Q3 24 | — | 4.8% | ||
| Q2 24 | — | -3.3% | ||
| Q1 24 | — | 6.4% | ||
| Q4 23 | 34.6% | 17.8% |
| Q3 25 | — | -7.8% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | -104.5% | 12.6% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | -6.9% | ||
| Q1 24 | — | 1.1% | ||
| Q4 23 | 44.4% | 9.8% |
| Q3 25 | — | $-0.60 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.36 | ||
| Q4 24 | $-0.41 | $1.01 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $-0.56 | ||
| Q1 24 | — | $0.08 | ||
| Q4 23 | $1.12 | $0.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9B | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $1.9B | $261.1M |
| 总资产 | $2.2B | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
| Q3 25 | — | $33.7M | ||
| Q2 25 | — | $29.3M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | $1.9B | $34.7M | ||
| Q3 24 | — | $32.4M | ||
| Q2 24 | — | $34.9M | ||
| Q1 24 | — | $20.0M | ||
| Q4 23 | $1.7B | $21.2M |
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | — | $261.1M | ||
| Q2 25 | — | $269.5M | ||
| Q1 25 | — | $268.8M | ||
| Q4 24 | $1.9B | $269.0M | ||
| Q3 24 | — | $263.4M | ||
| Q2 24 | — | $271.2M | ||
| Q1 24 | — | $285.8M | ||
| Q4 23 | $1.9B | $286.6M |
| Q3 25 | — | $596.9M | ||
| Q2 25 | — | $597.4M | ||
| Q1 25 | — | $589.8M | ||
| Q4 24 | $2.2B | $586.2M | ||
| Q3 24 | — | $584.4M | ||
| Q2 24 | — | $601.0M | ||
| Q1 24 | — | $609.9M | ||
| Q4 23 | $2.2B | $619.2M |
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-50.0M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $-50.3M | $11.5M |
| 自由现金流率自由现金流/营收 | -140.9% | 16.2% |
| 资本支出强度资本支出/营收 | 0.7% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-325.9M | $34.9M |
8季度趋势，按日历期对齐
| Q3 25 | — | $13.7M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | — | $8.5M | ||
| Q4 24 | $-50.0M | $13.3M | ||
| Q3 24 | — | $15.7M | ||
| Q2 24 | — | $15.8M | ||
| Q1 24 | — | $10.8M | ||
| Q4 23 | $-96.1M | $13.6M |
| Q3 25 | — | $11.5M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $5.7M | ||
| Q4 24 | $-50.3M | $7.6M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $3.2M | ||
| Q4 23 | $-96.8M | $8.5M |
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 8.6% | ||
| Q4 24 | -140.9% | 10.6% | ||
| Q3 24 | — | 14.0% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 4.4% | ||
| Q4 23 | -48.1% | 11.5% |
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | 0.7% | 8.0% | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 10.6% | ||
| Q4 23 | 0.4% | 6.9% |
| Q3 25 | — | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× | ||
| Q4 23 | -1.08× | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRSP
| Collaboration Revenue | $35.0M | 98% |
| Grant | $2.3M | 6% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
